COMMUNIQUÉS West-GlobeNewswire

Heron’s Key Announces Exciting Expansion with Upcoming Pre-Sales

31/01/2025 - 17:00

GIG HARBOR, Wash., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Heron’s Key , a premier Life Plan Community member of Emerald Communities, is thrilled to announce the highly anticipated expansion of our community, with pre-sales [...]

Correction: GUERBET : Calendrier financier de l'exercice 2025

31/01/2025 - 17:45

RECTIFICATIF - Calendrier financier de l’exercice 2025 Villepinte, le 13 janvier 2025 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, publie son [...]

Correction: GUERBET : Financial agenda for 2025

31/01/2025 - 17:45

CORRECTION - Financial agenda for 2025 Villepinte, 13 janvier 2025 : Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2025. [...]

Roche receives FDA approval for the first companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for ENHERTU

31/01/2025 - 17:45

As seen in the DESTINY-Breast06 trial, a pproximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast cancer patients may be considered HER2-ultralow. 1 These patients may now be eligible for a [...]

Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference

31/01/2025 - 17:59

Dr. Sigurd Berven to Highlight NOCISCAN Capabilities, Combining MR Spectroscopy and Augmented Intelligence (AI) NOCISCAN as New Gold Standard in Identifying a Source of Discogenic Pain BROOMFIELD, Colo., Jan. 31, 2025 ( [...]

EssilorLuxottica: Full-Year 2024 Results Conference Call Invitation

31/01/2025 - 18:00

Full-Year 2024 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial Officer, and Mr [...]

EssilorLuxottica: Full-Year 2024 Results Conference Call Invitation

31/01/2025 - 18:00

Full-Year 2024 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial Officer, and Mr [...]

Women in Science: Breaking Barriers with HNL Lab Medicine

31/01/2025 - 19:54

ALLENTOWN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Women are still vastly underrepresented in science, technology, engineering, and math (STEM) fields, with only 18% of women holding STEM jobs in the United States, [...]

Bavarian Nordic – Completion of Share Buy-Back Program

31/01/2025 - 20:31

COPENHAGEN, Denmark, January 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced and initiated on January 9, 2025, has now been completed, reaching an aggregate [...]

Oculis updates share capital for its existing at-the-market offering program

31/01/2025 - 22:00

ZUG, Switzerland, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company, has issued registered ordinary shares of the Company, each [...]

GH Research to Provide Update on Phase 2b Trial with GH001 in TRD

31/01/2025 - 22:01

DUBLIN, Jan. 31, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced [...]

Evaxion announces closing of $10.8 million public offering

31/01/2025 - 22:05

COPENHAGEN, Denmark, January 31, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced the closing of a [...]

The Ensign Group Schedules Year End 2024 Earnings Call for Thursday, February 6, 2025

31/01/2025 - 22:05

SAN JUAN CAPISTRANO, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]

Rentschler Biopharma announces strategic realignment of its global business operations

30/01/2025 - 14:00

LAUPHEIM, Germany, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its [...]

Liberation Labs Closes $50.5 Million Convertible Note

30/01/2025 - 14:00

Brings total deployable capital raised to date to $125 million and will enable completion of first biomanufacturing plant in Richmond, Indiana RICHMOND, Ind., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Liberation Labs has closed [...]

Mersana Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference

30/01/2025 - 14:00

CAMBRIDGE, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates ( [...]

Stereotaxis Announces First GenesisX Robotic System Order

30/01/2025 - 14:09

ST. LOUIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it has received the first order [...]

TOMI Environmental Reports Strong Start to 2025 with January Revenue Growth

30/01/2025 - 14:30

FREDERICK, Md., Jan. 30, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced positive [...]

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

30/01/2025 - 14:30

SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, [...]